Wistar Scientists Engineer New NK cell Engaging Immunotherapy Approaches to Target and potentially Treat recalcitrant Ovarian Cancer
01 nov. 2023 14h54 HE
|
The Wistar Institute
PHILADELPHIA, PA, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Wistar Institute’s David B. Weiner, Ph.D., executive vice president, director of the Vaccine & Immunotherapy Center (VIC) and W.W. Smith...
Wistar Researchers Discover Possible New Treatment for Triple-Negative Breast Cancer
19 sept. 2023 14h39 HE
|
The Wistar Institute
PHILADELPHIA, PA, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The...
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
22 août 2023 15h56 HE
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Wistar Researchers Discover Potential Target for Gastric Cancers Associated with Epstein-Barr Virus
22 août 2023 15h02 HE
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results...
Award-Winning Biotech Training Program Connects Philadelphians with Quality Jobs in the Region’s Rapidly Growing Life Sciences Sector
14 août 2023 11h14 HE
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Partners in Greater Philadelphia’s life sciences ecosystem are expanding their commitment to connecting a wider range of Philadelphians, including...
New Community Partnership Model Boosts Participant Inclusion into HIV Cure-Directed Research
08 août 2023 13h11 HE
|
The Wistar Institute
PHILADELPHIA, PA, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Scientists have long used community advisory boards to engage communities and provide feedback on studies, but this model has limitations. Now,...
Wistar-Led Team Awarded More Than $12 Million Grant from the NCI to Investigate Link Between Epstein-Barr Virus and Carcinomas
26 juil. 2023 10h21 HE
|
The Wistar Institute
PHILADELPHIA, PA, July 26, 2023 (GLOBE NEWSWIRE) -- It’s been known since the 1960s that Epstein-Barr Virus (EBV) causes a variety of cancers, but research has overwhelmingly focused on its...
Wistar Scientists Discover Innate Tumor Suppression Mechanism
04 mai 2023 10h34 HE
|
The Wistar Institute
PHILADELPHIA, PA, May 04, 2023 (GLOBE NEWSWIRE) -- The p53 gene is one of the most important in the human genome: the only role of the p53 protein that this gene encodes is to sense when a tumor is...
Researchers Identify a Plant-based Compound that Inhibits Reactivation of the HIV Viral Reservoir
30 mars 2023 10h07 HE
|
The Wistar Institute
PHILADELPHIA, March 30, 2023 (GLOBE NEWSWIRE) -- As of 2022, approximately 1.2 million people in the United States are living with HIV. Antiretroviral therapies have enabled many of these...
Wistar Scientists Identify a Gene Signature to Assess Cancer Risk in People
06 févr. 2023 15h45 HE
|
The Wistar Institute
PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- In a paper published in PNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar’s Ellen and Ronald Caplan Cancer Center and Ira Brind Professor and...